MedTrace Logo

Mapping the Human Colon Using Single Cell Sequencing

NCT05195502 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

The overall purpose of this study is to describe the cellular composition of the human colon and its gene expression using scRNAseq and scATACseq methods. This will potentially provide is with a detailed map of the colon aiding our understanding of how diseases of the colon develop as well as the colons influence on systemic diseases such as type II diabetes.

Conditions

  • Diabetes
  • Large Bowel Cancer
  • Inflammatory Bowel Diseases

Interventions

DIAGNOSTIC_TEST

Biopsy

Participants included in the study, will have additional biopsies performed during their colonoscopy

Sponsors & Collaborators

  • The Novo Nordisk Foundation Center for Basic Metabolic Research

    collaborator OTHER

  • Bispebjerg Hospital

    lead OTHER

Principal Investigators

  • Jacob Antonsen, MD · Bispebjerg Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-12-31
Completion
2024-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195502 on ClinicalTrials.gov